Metabolism-based
Cancer Therapy Symposium 2022

Wednesday, November 30, 2022・ONLINE

In the last decade cancer metabolism has emerged as a cancer hallmark. Although it has been almost a century since Otto Warburg described a difference in cellular metabolism in cancer cells, cancer-specific metabolic alterations have not been fully exploited therapeutically. Increasing numbers of studies showed both the complexity and the promise of targeting metabolism as a therapeutic strategy in cancer. It is time for scientists and clinicians working on this strategy to meet and exchange their experience.

With a translational focus, the symposium brings together oncologists and researchers interested in exploiting the metabolic bias of tumors for therapeutic interventions. It aims to shed light and bring to discussion novel translational approaches that are either currently under clinical testing or show translational potential in preclinical studies.  

Organizing Team

Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Peggy Jungke, Scientific and Event coordination at Mildred Scheel Early Career Center Dresden

Session 1

12:00–12:10 CET
Welcoming remarks
Mohamed Elgendy, Dresden, Germany
Ekaterina Balaian, Dresden, Germany

12:10–12:55 CET
Keynote talk
Joshua D. Rabinowitz, New Jersey, USA (requested)

12:55–13:30 CET
N.N.
Simón Méndez-Ferrer, Cambridge, UK (requested)

13:30–14:00 CET
Metabolic modulation of tumors with engineered bacteria for immunotherapy
Roger Geiger, Bellinzona, Switzerland

14:00–14:15 CET
Open discussion


break

Session 2

14:45–15:15 CET
N.N.
Annemie Schols, Maastricht, Netherlands (requested)

15:15–15:45 CET
Taking control of innate immunity with nanotherapeutics
Willem Mulder, New York, USA

15:45–16:15 CET
N.N.
Niels Abildgaard, Odense, Denmark (requested)

16:15–16:45 CET
Translation-based sensing of glutamine availability regulates cell fate and function within the tumor microenvironment
Natalya Pavlova, New York, USA

16:45–17:15 CET
Open discussion


break

17:30 CET
OUTLOOK

 

Ekaterina Balaian, Dr. med.
University Hospital Carl Gustav Carus
Institute for Clinical Chemistry and Laboratory Medicine
Technische Universität Dresden
Fetscherstraße 74
01307 Dresden, Germany

Mohamed Elgendy, Dr.
University Hospital Carl Gustav Carus Medical Clinic I
Institute for Clinical Chemistry and Laboratory Medicine
Technische Universität Dresden
Fetscherstraße 74
01307 Dresden, Germany

Roger Geiger, Phd
Institute for Research in Biomedicine  Via Francesco Chiesa 5
6500 Bellinzona, Switzerland

Simon Mendez-Ferrer, Prof.
University of Cambridge
Department of Haematology School of Clinical Medicine
Trinity Lane
CB2 1TN Cambridge, United Kingdom

Willem Mulder, Prof.
Mount Sinai School of Medicine
One Gustave L. Levy Place
NY 10029 New York, USA

Natalya Pavlova, Ph.D.
Memorial Sloan Kettering Cancer Center Sloan Kettering Institute
1275 York Avenue
NY 10065 New York, USA

Felix Manthei
Projektmanager

Mobile: +49 163 250 72 07
Phone: +49 351 25 933 210

GWT-TUD GmbH
Fachbereich Medizin

BioInnovationsZentrum
Tatzberg 47/49
01307 Dresden

Metabolism-based Cancer Therapy Symposium 2021

8th October 2021, Dresden

Bildnachweis: Graphic elements designed by Freepik